{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T14:40:56Z","timestamp":1720276856539},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jcv.2016.10.016","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T05:32:20Z","timestamp":1477978340000},"page":"86-89","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up"],"prefix":"10.1016","volume":"85","author":[{"given":"Marco","family":"Ripa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Pogliaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Chiappetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Nozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Coppalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Rovelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Tambussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"January (3)","key":"10.1016\/j.jcv.2016.10.016_bib0005","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJMoa1110187","article-title":"Enhanced CD4+T-cell recovery with earlier HIV-1 antiretroviral therapy","volume":"368","author":"Le","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"June (11)","key":"10.1016\/j.jcv.2016.10.016_bib0010","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/cid\/civ171","article-title":"Impact of the timing of initiation of antiretroviral therapy during primary HIV-1 infection the decay of cell-Associated HIV-DNA","volume":"60","author":"Laanani","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"August (9)","key":"10.1016\/j.jcv.2016.10.016_bib0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Insight start Study Group","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"March (2)","key":"10.1016\/j.jcv.2016.10.016_bib0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/COH.0b013e328324bbec","article-title":"The biology of CCR5 and CXCR4","volume":"4","author":"Alkhatib","year":"2009","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"April (7)","key":"10.1016\/j.jcv.2016.10.016_bib0025","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1476-5381.2010.01147.x","article-title":"Chemokine receptor CCR5: from AIDS to atherosclerosis","volume":"162","author":"Jones","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"June (2)","key":"10.1016\/j.jcv.2016.10.016_bib0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/QAI.0000000000000111","article-title":"A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals","volume":"66","author":"Markowitz","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.jcv.2016.10.016_bib0035","doi-asserted-by":"crossref","first-page":"e33948","DOI":"10.1371\/journal.pone.0033948","article-title":"Impact of multi-targeted antiretroviral treatment on gut T-cell depletion and HIV reservoir seeding during acute HIV infection","volume":"7","author":"Ananworanich","year":"2012","journal-title":"PLoS One"},{"issue":"January (3)","key":"10.1016\/j.jcv.2016.10.016_bib0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAD.0000000000000066","article-title":"Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection","volume":"28","author":"Puertas","year":"2014","journal-title":"AIDS"},{"issue":"April (4)","key":"10.1016\/j.jcv.2016.10.016_bib0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1473-3099(15)70021-6","article-title":"Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial","volume":"15","author":"Ch\u00e9ret","year":"2015","journal-title":"Lancet Infect. Dis."},{"issue":"September (13)","key":"10.1016\/j.jcv.2016.10.016_bib0050","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","article-title":"Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection","volume":"17","author":"Fiebig","year":"2003","journal-title":"AIDS"},{"issue":"May (5)","key":"10.1016\/j.jcv.2016.10.016_bib0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1473-3099(10)70319-4","article-title":"European guidelines on the clinical management of HIV-1 tropism testing","volume":"11","author":"Vandekerckhove","year":"2011","journal-title":"Lancet Infect. Dis."},{"issue":"October (10)","key":"10.1016\/j.jcv.2016.10.016_bib0060","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1093\/jac\/dks216","article-title":"Immune recovery and T cell subset analysis during effective treatment with maraviroc","volume":"67","author":"Cossarini","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"June (23)","key":"10.1016\/j.jcv.2016.10.016_bib0065","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2012-06-436345","article-title":"The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial","volume":"121","author":"Hunt","year":"2013","journal-title":"Blood"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216305777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216305777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T22:05:37Z","timestamp":1601157937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653216305777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":13,"alternative-id":["S1386653216305777"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2016.10.016","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2016.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}